New York: Parexel (NASDAQ:PRXL) Stock Has Just Had Its “Hold” Rating Reiterated by Jefferies. Shares now Have a $88.1 Target

September 17, 2017 - By Clifton Ray

 New York: Parexel (NASDAQ:PRXL) Stock Has Just Had Its

Investors sentiment decreased to 0.85 in 2016 Q4. Its down 0.15, from 1 in 2016Q3. It dropped, as 51 investors sold PAREXEL International Corporation shares while 100 reduced holdings. 46 funds opened positions while 83 raised stakes. 47.26 million shares or 0.12% more from 47.20 million shares in 2016Q3 were reported.

Moreover, Macquarie Ltd has 0% invested in PAREXEL International Corporation (NASDAQ:PRXL). Dean Assoc Ltd reported 62,375 shares. Associated Banc reported 32,935 shares stake. Commonwealth Equity Serv Inc owns 3,528 shares. 9,130 are owned by Thrivent For Lutherans. Teacher Retirement System Of Texas holds 4,286 shares or 0% of its portfolio. Phocas Financial Corporation reported 0.32% stake. Hutchin Hill Ltd Partnership reported 129,300 shares stake. 73,898 were reported by Amer Century Companies Inc. 711 are held by Parkside Fin National Bank And. Glenmede Tru Communication Na holds 0% or 13,940 shares. Whittier Tru Of Nevada Inc stated it has 494 shares or 0% of all its holdings. California State Teachers Retirement owns 108,337 shares. Ftb Advsrs owns 263 shares. 28,465 were accumulated by Tealwood Asset Management.

Parexel (NASDAQ:PRXL) Rating Reaffirmed

Jefferies now has a $88.1 price target on shares of Parexel (NASDAQ:PRXL). The price target suggests a potential upside of 0.17 % from the current stock price of Parexel (NASDAQ:PRXL). This rating was disclosed in a note on Monday, 11 September.

Investors sentiment decreased to 0.85 in 2016 Q4. Its down 0.15, from 1 in 2016Q3. It dropped, as 51 investors sold PAREXEL International Corporation shares while 100 reduced holdings. 46 funds opened positions while 83 raised stakes. 47.26 million shares or 0.12% more from 47.20 million shares in 2016Q3 were reported.

Moreover, Macquarie Ltd has 0% invested in PAREXEL International Corporation (NASDAQ:PRXL). Dean Assoc Ltd reported 62,375 shares. Associated Banc reported 32,935 shares stake. Commonwealth Equity Serv Inc owns 3,528 shares. 9,130 are owned by Thrivent For Lutherans. Teacher Retirement System Of Texas holds 4,286 shares or 0% of its portfolio. Phocas Financial Corporation reported 0.32% stake. Hutchin Hill Ltd Partnership reported 129,300 shares stake. 73,898 were reported by Amer Century Companies Inc. 711 are held by Parkside Fin National Bank And. Glenmede Tru Communication Na holds 0% or 13,940 shares. Whittier Tru Of Nevada Inc stated it has 494 shares or 0% of all its holdings. California State Teachers Retirement owns 108,337 shares. Ftb Advsrs owns 263 shares. 28,465 were accumulated by Tealwood Asset Management.

PAREXEL International Corporation (NASDAQ:PRXL) Ratings Coverage

Among 17 analysts covering Parexel International (NASDAQ:PRXL), 1 have Buy rating, 3 Sell and 13 Hold. Therefore 6% are positive. Parexel International has $88.1000 highest and $49 lowest target. $70.64’s average target is -19.68% below currents $87.95 stock price. Parexel International had 38 analyst reports since August 7, 2015 according to SRatingsIntel. Credit Suisse maintained the shares of PRXL in report on Friday, August 7 with “Outperform” rating. The firm has “Sell” rating given on Friday, December 16 by Goldman Sachs. Deutsche Bank maintained it with “Hold” rating and $65 target in Friday, October 28 report. The rating was upgraded by Goldman Sachs on Tuesday, May 23 to “Neutral”. Credit Suisse reinitiated PAREXEL International Corporation (NASDAQ:PRXL) rating on Friday, August 14. Credit Suisse has “Outperform” rating and $75 target. The firm has “Equal-Weight” rating by First Analysis given on Thursday, November 17. The rating was downgraded by Evercore on Wednesday, January 4 to “Hold”. The stock of PAREXEL International Corporation (NASDAQ:PRXL) has “Hold” rating given on Friday, August 7 by Deutsche Bank. On Thursday, October 27 the stock rating was downgraded by Robert W. Baird to “Neutral”. William Blair downgraded the shares of PRXL in report on Monday, July 18 to “Market Perform” rating.

The stock increased 0.02% or $0.02 on September 15, reaching $87.95. About 798,422 shares traded or 13.22% up from the average. PAREXEL International Corporation (NASDAQ:PRXL) has risen 35.35% since September 17, 2016 and is uptrending. It has outperformed by 18.65% the S&P500.

Wall Street await PAREXEL International Corporation (NASDAQ:PRXL) to release earnings on October, 25. Analysts forecast earnings per share of $0.89, up exactly $0.13 or 17.11 % from 2014’s $0.76 EPS. The expected PRXL’s profit could reach $45.54 million giving the stock 24.71 P/E in the case that $0.89 earnings per share is reported. After posting $1.02 EPS for the previous quarter, PAREXEL International Corporation’s analysts now forecast -12.75 % negative EPS growth.

PAREXEL International Corporation is a biopharmaceutical outsourcing services company. The company has market cap of $4.50 billion. The Firm provides a range of expertise in clinical research, clinical logistics, medical communications, consulting, commercialization, and technology services and products to pharmaceutical, biotechnology and medical device industries. It has a 42.82 P/E ratio. The Company’s divisions include Clinical Research Services (CRS), PAREXEL Consulting Services (PC) and PAREXEL Informatics (PI).

More notable recent PAREXEL International Corporation (NASDAQ:PRXL) news were published by: Businesswire.com which released: “PAREXEL International Reports Fourth Quarter and Fiscal Year 2017 Results” on August 28, 2017, also Reuters.com with their article: “Contract research firm Parexel International explores sale: sources” published on May 08, 2017, Seekingalpha.com published: “Upside Potential From Possible Transaction At PAREXEL International” on May 25, 2017. More interesting news about PAREXEL International Corporation (NASDAQ:PRXL) were released by: Reuters.com and their article: “Pamplona Capital to take Parexel private for $4.5 billion” published on June 20, 2017 as well as Businesswire.com‘s news article titled: “PAREXEL and Osaka International Cancer Institute Form Alliance to Advance …” with publication date: August 21, 2017.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: